ReviewDiabetes, metabolic syndrome and obesity : targets and therapy2025

Comparative Safety of GLP-1/GIP Co-Agonists Versus GLP-1 Receptor Agonists for Weight Loss in Patients with Obesity or Overweight: A Systematic Review.

Zeyu Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.